78 related articles for article (PubMed ID: 23346882)
1. Menatetrenone for the treatment of osteoporosis.
Iwamoto J; Sato Y
Expert Opin Pharmacother; 2013 Mar; 14(4):449-58. PubMed ID: 23346882
[TBL] [Abstract][Full Text] [Related]
2. Vitamin K₂ therapy for postmenopausal osteoporosis.
Iwamoto J
Nutrients; 2014 May; 6(5):1971-80. PubMed ID: 24841104
[TBL] [Abstract][Full Text] [Related]
3. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW
Osteoporos Int; 2015 Mar; 26(3):1175-86. PubMed ID: 25516361
[TBL] [Abstract][Full Text] [Related]
4. Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial.
Jiang Y; Zhang ZL; Zhang ZL; Zhu HM; Wu YY; Cheng Q; Wu FL; Xing XP; Liu JL; Yu W; Meng XW
Clin Interv Aging; 2014; 9():121-7. PubMed ID: 24426779
[TBL] [Abstract][Full Text] [Related]
5. Effects of vitamin K in postmenopausal women: mini review.
Guralp O; Erel CT
Maturitas; 2014 Mar; 77(3):294-9. PubMed ID: 24342502
[TBL] [Abstract][Full Text] [Related]
6. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E
Osteoporos Int; 2013 Sep; 24(9):2499-507. PubMed ID: 23525894
[TBL] [Abstract][Full Text] [Related]
7. Low-dose menaquinone-4 improves γ-carboxylation of osteocalcin in young males: a non-placebo-controlled dose-response study.
Nakamura E; Aoki M; Watanabe F; Kamimura A
Nutr J; 2014 Aug; 13():85. PubMed ID: 25163392
[TBL] [Abstract][Full Text] [Related]
8. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y
J Bone Miner Metab; 2014 Mar; 32(2):142-50. PubMed ID: 23702931
[TBL] [Abstract][Full Text] [Related]
9. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).
Vossen LM; Schurgers LJ; van Varik BJ; Kietselaer BL; Vermeer C; Meeder JG; Rahel BM; van Cauteren YJ; Hoffland GA; Rennenberg RJ; Reesink KD; de Leeuw PW; Kroon AA
Nutrients; 2015 Oct; 7(11):8905-15. PubMed ID: 26516910
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Daily Intake of Vitamin K(2) (Menaquinone-7) Improves Osteocalcin γ-Carboxylation: A Double-Blind, Randomized Controlled Trials.
Inaba N; Sato T; Yamashita T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):471-80. PubMed ID: 26875489
[TBL] [Abstract][Full Text] [Related]
11. Regulation of bone remodeling by vitamin K2.
Myneni VD; Mezey E
Oral Dis; 2017 Nov; 23(8):1021-1028. PubMed ID: 27976475
[TBL] [Abstract][Full Text] [Related]
12. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C
Thromb Haemost; 2015 May; 113(5):1135-44. PubMed ID: 25694037
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.
Caluwé R; Vandecasteele S; Van Vlem B; Vermeer C; De Vriese AS
Nephrol Dial Transplant; 2014 Jul; 29(7):1385-90. PubMed ID: 24285428
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K for the primary prevention of cardiovascular disease.
Hartley L; Clar C; Ghannam O; Flowers N; Stranges S; Rees K
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011148. PubMed ID: 26389791
[TBL] [Abstract][Full Text] [Related]
15. Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis.
Shearer MJ; Newman P
J Lipid Res; 2014 Mar; 55(3):345-62. PubMed ID: 24489112
[TBL] [Abstract][Full Text] [Related]
16. Comparison of concurrent treatment with vitamin K
Tanaka S; Miyazaki T; Uemura Y; Miyakawa N; Gorai I; Nakamura T; Fukunaga M; Ohashi Y; Ohta H; Mori S; Hagino H; Hosoi T; Sugimoto T; Itoi E; Orimo H; Shiraki M
J Bone Miner Metab; 2017 Jul; 35(4):385-395. PubMed ID: 27484436
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K and bone health in older adults.
Shah K; Gleason L; Villareal DT
J Nutr Gerontol Geriatr; 2014; 33(1):10-22. PubMed ID: 24597993
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K and bone health.
Hamidi MS; Gajic-Veljanoski O; Cheung AM
J Clin Densitom; 2013; 16(4):409-13. PubMed ID: 24090644
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Su S; He N; Men P; Song C; Zhai S
Osteoporos Int; 2019 Jun; 30(6):1175-1186. PubMed ID: 30734066
[TBL] [Abstract][Full Text] [Related]
20. Statement of Retraction.
Expert Opin Pharmacother; 2019 Aug; 20(12):1531. PubMed ID: 31437064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
